By
AmyT on
December 8, 2008
You like games? Got diabetes? Then you are going to love this: A small Massachusetts-based startup company called Glymetrix has created an online game that aims to help you improve your diabetes management, but without all the boring and preachy “diabetes stuff.”
Seriously, the game is modeled after Trivial Pursuit, Jeopardy and similar games you’ve probably played before or watched on TV. Only about 20% of the total content is diabetes-related. (Categories include Sports, Television,…
Read more »
By
AmyT on
December 4, 2008
Who’s familiar with the ICE (In Case of Emergency) program that encourages people to enter emergency contacts in their cell phone address book under the name “ICE” — like “ICE – Dad” or “ICE – Janie“? Then you add some brief notes about your medical condition in the address book entry. Funny to think that there are so many companies out there developing fancy databases and chipsets for medical emergency alerts when we all actually carry…
Read more »
By
AmyT on
December 3, 2008
That’s what it feels like, anyway. A millennium of skin malfunctions over here that are making my diabetes and gluten intolerance genuinely intolerable of late! (A TMI post? Read at your own risk)
The latest bout of troubles kicked off this summer when I took the new Abbott Navigator CGM sensor for a test drive. The very latex-y adhesive used to adhere that product to the skin did not get along with my skin at…
Read more »
By
AmyT on
November 20, 2008
So my “mole” who attended the Diabetes Technology Society meeting in Maryland last week got back to me, and the news was kind of disappointing. On the whole, it doesn’t sound like there’s anything particularly new under the sun for us PWDs at the moment; it’s all about more baby steps in research and development.
But Aaron Kowalski, Research Director of the JDRF, might disagree with me there. He delivered a keynote address entitled “Accelerating…
Read more »
By
AmyT on
November 12, 2008
While we’re on the topic of diabetes technologies and advancements this week, I’d like to share what I’ve learned about two more companies working on some alluring diabetes innovations.
DiaSome Pharmaceuticals, located in Conshohoken, PA, is developing a “proprietary nanotechnology cell-receptor targeting system” designed to deliver insulin to the hepatocyte cells in the liver via both oral and injectable drug routes. According to their documentation, “the site-specific targetting of insulin essentially restores ‘normal physiology’ to…
Read more »
